Remarkable remission of an invasive giant prolactinoma under high-dose bromocriptine monotherapy

Pol Arch Intern Med. 2017 Aug 9;127(7-8):559-560. doi: 10.20452/pamw.4079. Epub 2017 Aug 7.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Bromocriptine / therapeutic use*
  • Humans
  • Male
  • Pituitary Neoplasms / drug therapy*
  • Prolactinoma / drug therapy*
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Bromocriptine